{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:23:54Z","timestamp":1789788234988,"version":"4.0.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cmi.2021.02.005","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:32:59Z","timestamp":1613561579000},"page":"1230-1241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Serology anno 2021\u2014fungal infections: from invasive to chronic"],"prefix":"10.1016","volume":"27","author":[{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldina","family":"Samardzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.02.005_bib1","first-page":"E216","article-title":"Diagnosis of breakthrough fungal infections in the clinical mycology laboratory: an ECMM consensus statement","volume":"6","author":"Jenks","year":"2020","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.cmi.2021.02.005_bib2","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J\u00a0Fungi"},{"key":"10.1016\/j.cmi.2021.02.005_bib3","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1093\/mmy\/myy103","article-title":"How to make a fast diagnosis in invasive aspergillosis","volume":"57","author":"Lass-Fl\u00f6rl","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2021.02.005_bib4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID\u2217 guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40121-020-00315-4","article-title":"Pulmonary aspergillosis: an evolving challenge for diagnosis and treatment","volume":"9","author":"Russo","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.cmi.2021.02.005_bib7","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12281-018-0321-1","article-title":"Role of serological tests in the diagnosis of mold infections","volume":"12","author":"Richardson","year":"2018","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.cmi.2021.02.005_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"European Respiratory Society. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2021.02.005_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.201903-0587LE","article-title":"Detection of invasive aspergillosis in critically ill patients with influenza: the role of plasma galactomannan","volume":"200","author":"van de Groep","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2021.02.005_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","article-title":"Invasive tracheobronchial aspergillosis in critically iII patients with severe influenza A clinical trial","volume":"202","author":"Nyga","year":"2020","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.cmi.2021.02.005_bib12","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intens Care Med"},{"key":"10.1016\/j.cmi.2021.02.005_bib13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.202005-2018LE","article-title":"Detection of invasive pulmonary aspergillosis in COVID-19 with nondirected BAL","volume":"202","author":"Van Biesen","year":"2020","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.cmi.2021.02.005_bib14","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cmi.2021.02.005_bib15","first-page":"131","article-title":"Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis","volume":"81","author":"Bassetti","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib16","article-title":"Galactomannan and 1,3-\u03b2-d-glucan testing for the diagnosis of invasive aspergillosis","volume":"2","author":"Lamoth","year":"2016","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.cmi.2021.02.005_bib17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/14737159.2020.1820864","article-title":"Point-of-care diagnostics for invasive aspergillosis: nearing the finish line","volume":"20","author":"Jenks","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cmi.2021.02.005_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/myc.12881","article-title":"Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test in bronchoalveolar lavage","volume":"62","author":"Jenks","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2021.02.005_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/mmy\/myw116","article-title":"Aspergillus serology: have we arrived yet?","volume":"55","author":"Richardson","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2021.02.005_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.21037\/jtd.2019.01.07","article-title":"Galactomannan detection in bronchoalveolar lavage fluid corrected by urea dilution for the diagnosis of invasive pulmonary aspergillosis among nonneutropenic patients","volume":"11","author":"Yu","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s13054-020-03367-7","article-title":"Point of care Aspergillus testing in intensive care patients","volume":"24","author":"Mercier","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2021.02.005_bib22","first-page":"610","article-title":"A\u00a0mortality prediction rule for hematology patients with invasive aspergillosis based on serum galactomannan kinetics","volume":"9","author":"Mercier","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cmi.2021.02.005_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/myc.12694","article-title":"Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients","volume":"61","author":"Castillo","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2021.02.005_bib24","article-title":"Performance of the bronchoalveolar lavage fluid Aspergillus galactomannan lateral flow assay with Cube Reader for diagnosis of invasive pulmonary aspergillosis: a multicenter cohort study","author":"Jenks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/myc.13012","article-title":"Clinical application of Aspergillus lateral flow device in bronchoalveolar lavage fluid of patients with classic risk factors for invasive pulmonary aspergillosis","volume":"62","author":"Linder","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2021.02.005_bib26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/mmy\/myz079","article-title":"Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: a comparative multicenter study","volume":"58","author":"Mercier","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2021.02.005_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bjh.13114","article-title":"A\u00a0comprehensive diagnostic approach using galactomannan, targeted \u03b2-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients","volume":"168","author":"Ceesay","year":"2015","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.cmi.2021.02.005_bib28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cmi.2019.12.009","article-title":"Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study","volume":"26","author":"Lee","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib29","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fmicb.2019.01438","article-title":"Role of the Aspergillus-specific IgG and IgM test in the diagnosis and follow-up of chronic pulmonary aspergillosis","volume":"10","author":"Li","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1186\/s12879-019-4303-x","article-title":"Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis","volume":"19","author":"Ma","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children","volume":"25","author":"Warris","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib32","first-page":"351","article-title":"A\u00a0systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-d-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"He","year":"2015","journal-title":"J\u00a0Microbiol Immunol"},{"key":"10.1016\/j.cmi.2021.02.005_bib33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11046-020-00479-0","article-title":"Performance of the (1,3)- \u03b2-d-glucan assay on bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis","volume":"185","author":"Linder","year":"2020","journal-title":"Mycopathologia"},{"issue":"9","key":"10.1016\/j.cmi.2021.02.005_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmi.2020.05.024","article-title":"Diagnostic accuracy of serum (1-3)- \u03b2-d-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis","volume":"26","author":"Del Corpo","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib35","first-page":"CD009833","article-title":"(1\u21923)-\u03b2-d-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people","volume":"7","author":"White","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2021.02.005_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ajcp\/aqy135","article-title":"Diagnostic accuracy of \u03b2-d-glucan (Fungitell) testing among patients with hematologic malignancies or solid organ tumors: a systematic review and meta-analysis","volume":"151","author":"White","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cmi.2021.02.005_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","article-title":"Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline","volume":"200","author":"Hage","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2021.02.005_bib38","article-title":"Prospective evaluation of the turbidimetric \u03b2-d-glucan assay and two lateral flow assays on serum in invasive aspergillosis","author":"Mercier","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib39","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib40","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1164\/rccm.201211-2069OC","article-title":"Fungal Infection Network of S. Beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis","volume":"188","author":"Tissot","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2021.02.005_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02094-19","article-title":"Efficacy of cerebrospinal fluid \u03b2-d-glucan diagnostic testing for fungal meningitis: a systematic review","volume":"58","author":"Davis","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jpids\/piv014","article-title":"(1\u21923)-\u03b2-d-Glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients","volume":"5","author":"Salvatore","year":"2016","journal-title":"J\u00a0Pediat Inf Dis Soc"},{"key":"10.1016\/j.cmi.2021.02.005_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cmi.2016.05.020","article-title":"Lower sensitivity of serum (1,3)- \u03b2-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis","volume":"22","author":"Mikulska","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/mmy\/myu018","article-title":"Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis","volume":"52","author":"Chumpitazi","year":"2014","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2021.02.005_bib45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/myc.12482","article-title":"Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection","volume":"59","author":"Duettmann","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2021.02.005_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s15010-018-1224-3","article-title":"Serological biomarkers of candidemia: a retrospective evaluation of three assays","volume":"47","author":"Dichtl","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2021.02.005_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11046-017-0238-1","article-title":"A\u00a0retrospective assessment of four antigen assays for the detection of invasive candidiasis among high-risk hospitalized patients","volume":"183","author":"Hartl","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.cmi.2021.02.005_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/myc.13035","article-title":"Diagnostic value of Candida mannan antigen and anti-mannan IgG and IgM antibodies for Candida infection","volume":"63","author":"Wang","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2021.02.005_bib49","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/jac\/dkv090","article-title":"Candida biomarkers in patients with candidaemia and bacteraemia","volume":"70","author":"Martinez-Jimenez","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2021.02.005_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13054-016-1324-3","article-title":"Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions","volume":"20","author":"Leon","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2021.02.005_bib51","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1590\/s1678-9946202062025","article-title":"Performance of a new Candida anti-mannan IgM and IgG assays in the diagnosis of candidemia","volume":"62","author":"Meng","year":"2020","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.cmi.2021.02.005_bib52","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1186\/s13104-019-4829-4","article-title":"Point of care testing evaluation of lateral flow immunoassay for diagnosis of cryptococcus meningitis in HIV-positive patients at an urban hospital in Nairobi, Kenya, 2017","volume":"12","author":"Gitonga","year":"2019","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.cmi.2021.02.005_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00441-20","article-title":"Evaluation of a novel semiquantitative cryptococcal antigen lateral flow assay in patients with advanced HIV disease","volume":"58","author":"Jarvis","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib54","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12866-017-1093-4","article-title":"Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis","volume":"17","author":"Kwizera","year":"2017","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12879-019-3744-6","article-title":"Development of a lateral flow recombinase polymerase amplification assay for rapid and visual detection of Cryptococcus neoformans\/C. gattii in cerebral spinal fluid","volume":"19","author":"Ma","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190652","article-title":"Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection","volume":"13","author":"Mpoza","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2021.02.005_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01238-18","article-title":"Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing","volume":"57","author":"Rajasingham","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02046-19","article-title":"Evaluation of serum cryptococcal antigen testing using two novel semiquantitative lateral flow assays in persons with cryptococcal antigenemia","volume":"58","author":"Skipper","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib59","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3109\/1040841X.2014.982509","article-title":"The cryptococcal antigen lateral flow assay: a point-of-care diagnostic at an opportune time","volume":"42","author":"Tang","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib60","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12879-020-05368-x","article-title":"Evaluation of lateral flow immunochromatographic assay for diagnostic accuracy of cryptococcosis","volume":"20","author":"Xie","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02307-20","article-title":"Diagnostic accuracy of the Biosynex CryptoPS cryptococcal antigen semi-quantitative lateral flow assay in patients with advanced HIV disease","author":"Tenforde","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib62","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1590\/s1678-9946201860001","article-title":"Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center","volume":"60","author":"Vidal","year":"2018","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.cmi.2021.02.005_bib63","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/QAI.0000000000001721","article-title":"Brief report: point of care cryptococcal antigen screening: pipetting finger-prick blood improves performance of immunomycologics lateral flow assay","volume":"78","author":"Wake","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cmi.2021.02.005_bib64","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2147\/IDR.S178391","article-title":"The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococcosis in patients without HIV infection","volume":"11","author":"Zhou","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2021.02.005_bib65","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/cid\/ciy326","article-title":"Urine antigen detection as an aid to diagnose invasive aspergillosis","volume":"67","author":"Marr","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.02.005_bib66","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.cmi.2017.09.018","article-title":"Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients","volume":"24","author":"Bhimji","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib67","doi-asserted-by":"crossref","first-page":"26724","DOI":"10.18632\/oncotarget.25477","article-title":"Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis","volume":"9","author":"Calmettes","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cmi.2021.02.005_bib68","doi-asserted-by":"crossref","first-page":"20190693","DOI":"10.1259\/bjr.20190693","article-title":"High prevalence of peribronchial focal lesions of airway invasive aspergillosis in hematological cancer patients with prolonged neutropenia","volume":"93","author":"Casutt","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib69","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cmi.2018.05.006","article-title":"Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis","volume":"24","author":"Nucci","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00138-19","article-title":"Candida in the respiratory tract potentially triggers galactomannan positivity in nonhematological patients","volume":"63","author":"Aigner","year":"2019","journal-title":"Antimicrob Agents Ch"},{"key":"10.1016\/j.cmi.2021.02.005_bib71","author":"Kauffman"},{"key":"10.1016\/j.cmi.2021.02.005_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00284-018-1582-1","article-title":"Aspergillus galactomannan detection: trichoderma as a cause of positive results","volume":"76","author":"Markantonatou","year":"2019","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jpids\/pis044","article-title":"Galactomannan antigen testing for diagnosis of invasive aspergillosis in pediatric hematology patients","volume":"1","author":"Fisher","year":"2012","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"key":"10.1016\/j.cmi.2021.02.005_bib74","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/JCM.02969-15","article-title":"Urine Galactomannan-to-creatinine ratio for detection of invasive aspergillosis in patients with hematological malignancies","volume":"54","author":"Reischies","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00136-19","article-title":"Evaluation of a novel Aspergillus antigen enzyme-linked immunosorbent assay","volume":"57","author":"Dichtl","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib76","doi-asserted-by":"crossref","first-page":"e01913","DOI":"10.1128\/JCM.01913-18","article-title":"Diagnosing invasive pulmonary aspergillosis in hematology patients: a retrospective multicenter evaluation of a novel lateral flow device","volume":"57","author":"Mercier","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib77","doi-asserted-by":"crossref","first-page":"1563 e1","DOI":"10.1016\/j.cmi.2019.08.009","article-title":"Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY): real-life data from a multicentre study","volume":"25","author":"Lass-Florl","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.02.005_bib78","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/myc.13176","article-title":"Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: a retrospective two-centre study","volume":"63","author":"Scharmann","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2021.02.005_bib79","first-page":"e01006","article-title":"An evaluation of the performance of the IMMY Aspergillus galactomannan enzyme linked immunosorbent assay when testing serum to aid in the diagnosis of invasive aspergillosis","author":"White","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib80","first-page":"302","article-title":"Aspergillus antibody detection: diagnostic strategy and technical considerations from the Societe Francaise de Mycologie Medicale (French Society for Medical Mycology) expert committee","volume":"55","author":"Persat","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2021.02.005_bib81","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkv419","article-title":"1,3- \u03b2-d-Glucan contamination of common antimicrobials","volume":"71","author":"Liss","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2021.02.005_bib82","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/JCM.00751-17","article-title":"Low Cryptococcus antigen titers as determined by lateral flow assay should be interpreted cautiously in patients without prior diagnosis of cryptococcal Infection","volume":"55","author":"Dubbels","year":"2017","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.02.005_bib83","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","author":"Koehler","year":"2020","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2100080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2100080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:28:29Z","timestamp":1761118109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2100080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1198743X2100080X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.02.005","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serology anno 2021\u2014fungal infections: from invasive to chronic","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}